Aurobindo Pharma receives US FDA Approval for Norethindrone Acetate Tablets

11 Jan 2016

1

Aurobindo Pharma Limited today said  it has received final approval from the US Food & Drug Administration to manufacture and market Norethindrone Acetate Tablets USP, in 5mg dosage.

This is Aurobindo Pharma's 57th ANDA to be approved out of formulation facility in Hyderabad, for manufacturing oral non-antibiotic products.

"The approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Aygestin Tablets, 5 mg, of Duramed Pharmaceuticals," Aurobindo Pharma said in a statement.

Norethindrone Acetate Tablet is used in the treatment of endometriosis, uterine bleeding caused by abnormal hormone levels, and secondary amenorrhea.

The approved product has an estimated market size of $24 million for the 12 months ending November 2015 according to IMS.

Aurobindo now has a total of 230 ANDA approvals (199 Final approvals including 10 from Aurolife Pharma LLC and 31 Tentative approvals) from USFDA.

Business History Videos

History of hovercraft Part 3 | Industry study | Business History

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2 | Industry study | Business History

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1 | Industry study | Business History

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | Industry study | Business History

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more
View details about the software product Informachine News Trackers